The aspartate which is also produced is translocated out of the mitochondrion, in exchange for glutamate, through the actions of the SLC25A13 antiporter
Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013
In both preclinical and clinical studies, semaglutide has demonstrated robust improvements in glycemic control together with significant reductions in body weight, largely through the modulation of central appetite pathways and reduced food intake [2,3]
Because it carries two amine groups, it acts as a primary non-toxic transporter of ammonia in the blood, safely moving this metabolic waste product from peripheral tissues to the liver and kidneys for processing and excretion